Meitheal Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?
MEITHEAL has sixty-nine approved drugs.
Drugs and US Patents for Meitheal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meitheal | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 214505-001 | Sep 8, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Meitheal | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 204843-001 | Jan 18, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Meitheal | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 075259-001 | Sep 22, 2000 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Meitheal | TIGECYCLINE | tigecycline | POWDER;INTRAVENOUS | 214020-001 | May 13, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Meitheal | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 206189-001 | Jun 26, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Meitheal | OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 075959-001 | Nov 21, 2005 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MEITHEAL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
Similar Applicant Names
Here is a list of applicants with similar names.